NEW YORK: Making money from marijuana in the past used to require navigating the red tape of the law. Jim Cramer has had his eye on one stock that is giving him quite a buzz.
GW Pharmaceuticals is a speculative drug company that has a history of volatile trading. However, Cramer wouldn’t be surprised if the more than 10 percent jump in the stock on Wednesday is just the start of this stock being… high.
To find out where this stock could be headed, the “Mad Money” host sat down with Justin Gover, the CEO of GW Pharmaceuticals.
Cramer considers GW Pharma to be the one really legitimate play on medicinal marijuana, as it uses marijuana to develop real medicine. Additionally, it is a British company that doesn’t need to worry about the U.S. laws that make owning large quantities of pot a felony.